HCV Drugs

Medical Advocates
HCV Infection/Disease

Interferon Therapy

General Reports
Consensus Interferon
Interferon Alpha
Recombinant Interferon-Alpha
Interferon Alpha/RBV
Interferon Alpha-2a
Interferon Alpha-2b
Interferon Alpha-2a/RBV
Interferon Alpha-2b/RBV
Interferon Alpha-2b/RBV/AMT Interferon Beta
Albinterferon-alfa 2b
Peg Interferon-Alfa-2a
Peg Interferon-Alfa-2b

HCV Drugs Main Page

Main New/Newsworthy

Home Page

Last Update: November 30, 2017
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports

Journal Papers, Abstracts, and Commentaries

FULL-TEXT ARTICLE
Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin.
Barbosa MED, Zaninotto AL, de Campos Mazo DF, et al
BMC Gastroenterol. 2017 Nov 25;17(1):122.
Paper

Impact of Sustained Virological Response to Interferon Therapy on Recurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Shinkawa H, Hasegawa K, Arita J, et al
Ann Surg Oncol. 2017 Jul 13.
Abstract

Interferon Therapy Exacerbated Pulmonary Hypertension in a Patient with Hepatitis C Virus Infection: Pathogenic Interplay among Multiple Risk Factors.
Tsuchiya H, Kioka H, Ozu K, et al
Intern Med. 2017;56(9):1061-1065.
Abstract

Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up.
Mak SK, Sin HK, Lo KY, et al
Clin Exp Nephrol. 2017 Jan 12.
Abstract

FULL-TEXT ARTICLE
Interactive Effects of Immunoglobulin Gamma and Human Leucocyte Antigen Genotypes on Response to Interferon Based Therapy of Hepatitis C Virus.
Gomaa HE, Mahmoud M, Saad NE, et al
Open Access Maced J Med Sci. 2015 Jun 15;
Paper

FULL-TEXT ARTICLE
Ophthalmological side effects of interferon therapy of chronic hepatitis C.
Medhat E, Esmat G, Hamza E, et al
Hepatobiliary Surg Nutr. 2016 Jun;5(3):209-16.
Paper

Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan.
Hsu YH, Hung PH, Muo CH, et al
Medicine (Baltimore). 2015 Nov;94(47):e2113.
Abstract

FULL-TEXT ARTICLE
Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection.
Sung PS, Shin EC, Yoon SK.
Int J Mol Sci. 2015 Oct 7;16(10):23683-23694.
Paper

Successful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis C.
Noritake H, Kobayashi Y, Ooba Y, et al
J Interferon Cytokine Res. 2015 Aug 26
Abstract

FULL-TEXT ARTICLE
Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study
Masaki N, Yamagiwa Y, Shimbo T, et al
BMC Public Health. 2015 Jun 19;15:566.
Paper

Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients.
Chen H, Zhang Y, Huang P, et al
J Biomed Res. 2014 Nov;28(6):476-483.
Abstract

Pulmonary arterial hypertension associated with the use of interferon therapy for chronic hepatitis C infection complicated by extrinsic left main coronary artery compression.
Anderson RD, Thompson A, Burns AT.
Intern Med J. 2014 Oct;44(10):1027-30.
Abstract

Supervised conventional interferon α2a in combination with ribavirin therapy is the preferred alternative for treatment of chronic hepatitis C.
Rehan HS, Manak S, Yadav M.
Indian J Pharmacol. 2014 Sep;46(5):490-2
Abstract

FULL-TEXT ARTICLE
Analysis of genotype 1b hepatitis C virus IRES in serum and peripheral blood mononuclear cells in patients treated with interferon and ribavirin
Bukowska-Ośko I, Caraballo Cort�s K, et al
Biomed Res Int. 2014;2014:175405.
Paper

FULL-TEXT ARTICLE
Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma.
Saito T, Chiba T, Suzuki E, Shinozaki M, et al
Int J Med Sci. 2014 May 7;11(7):707-12
Paper

Interferon treatment of chronic hepatitis C: Basic immunobiology and immunopathology of the liver
Mazana JS.
Rev Esp Sanid Penit. 2013 Jun;15(1):16-22.
Abstract

Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.
Kojima A, Kakizaki S, Hosonuma KI, et al
J Gastroenterol Hepatol. 2013 Jan 10.
Abstract

Vitamin A deficiency is associated with HCV chronic infection and with unresponsiveness to interferon based antiviral therapy.
Bitetto D, Bortolotti N, Falleti E, et al
Hepatology. 2012 Dec 5.
Abstract

Consensus Interferon

Journal Papers, Abstracts, and Commentaries

Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to
Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study.
Yee HS, Currie SL, Tortorice K, et al
Dig Dis Sci. 2011 Jun
Abstract

U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for "Difficult-to-Treat" HCV
Genotype 1 Patients.
Ho SB, Aqel B, Dieperink E, et al
Dig Dis Sci. 2011 Jan 11
Abstract

Comparative efficacy and overall safety of different doses of consensus interferon for
treatment of chronic HCV infection: a systematic review and meta-analysis.
Alavian SM, Behnava B, Tabatabaei SV.
Eur J Clin Pharmacol. 2010 Sep 21.
Abstract

FULL-TEXT ARTICLE
Management of chronic hepatitis C treatment failures: role of consensus interferon.
Gonzalez SA, Keeffe EB.
Biologics. 2009;3:141-50.
Paper

FULL TEXT PDF ARTICLE
Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C.
Tahara H, Kojima A, Hirokawa T, et al
Intern Med. 2007;46(8):473-6.
Paper

FULL-TEXT ARTICLE
Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C
patients with genotype 2.
Suzuki H, Sato K, Takagi H, et al
World J Gastroenterol. 2006 Feb 14;12(6):945-50
Paper

Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to,
or relapsed after, interferon alpha-2b and ribavirin in combination: an Italian pilot study.
Barbaro G, Barbarini G.
Eur J Gastroenterol Hepatol 2002 May;14(5):477-83
Abstract

Interferon Alpha

General Reports

Journal Papers, Abstracts, and Commentaries

Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
Cozen ML, Ryan JC, Shen H, et al
Dig Dis Sci. 2016 Apr 8.
Abstract

Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection.
Wang KL, Xing HQ, Zhao H, et al
World J Gastroenterol. 2014 Apr 14;20(14):4071-5.
Abstract

Comparison of Immune Restoration in Early versus Late Interferon Alpha
Therapy against Hepatitis C Virus.
Abdel-Hakeem MS, B�dard N, Badr G, et al
J Virol. 2010 Jul 28
Abstract

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis
C virus infection.
Stegmann KA, Bj�rkstr�m NK, Veber H, et al
Gastroenterology. 2010 May;138(5):1885-97
Abstract

Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5.
Antaki N, Hermes A, Hadad M, et al
J Viral Hepat. 2008 May;15(5):383-6.
Abstract

Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and
nonalcoholic Fatty liver disease.
Banks SE, Riley Iii TR, Naides SJ.
Dig Dis Sci. 2007 May;52(5):1177-82.
Abstract

Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic
hepatitis C: a systematic review and economic evaluation.
Shepherd J, Jones J, Hartwell D, et al
Health Technol Assess. 2007 Mar;11(11):1-224
Abstract

FULL TEXT ARTICLE
Interferon alpha therapy for hepatitis C: treatment completion and response rates among
patients with substance use disorders.
Huckans MS, Loftis JM, Blackwell AD
Subst Abuse Treat Prev Policy. 2007 Jan 12;2:4.
Paper

Dermatologic Disorders Associated With Chronic Hepatitis C: Effect of Interferon Therapy.
Berk DR, Mallory SB, Keeffe EB, Ahmed A
Clin Gastroenterol Hepatol. 2006 Aug 16;
Abstract

Treatment of interferon-alpha for chronic hepatitis C.
Moriyama M, Arakawa Y.
Expert Opin Pharmacother. 2006 Jun;7(9):1163-79.
Abstract

Efficacy of Interferon-alpha in the Treatment of Chronic Hepatitis C in Dialysis Patients:
Two Therapeutic Protocols Compared.
Grgurevic I, Vince A, Buljevac M, et al
Nephron Clin Pract. 2005 Dec 21;103(1):c8-c11
Abstract

Acquired factor VIII inhibitor in patients with hepatitis C virus infection and the role of
interferon-alpha: A case report.
Schreiber ZA, Brau N.
Am J Hematol. 2005 Nov 28;80(4):295-298
Abstract

Adverse Events

Journal Papers, Abstracts, and Commentaries

Understanding clinical risk decision making regarding development of depression during interferon-alpha treatment for hepatitis-C: A qualitative interview study.
Hepgul N, Kodate N, Anderson JE, et al
Int J Nurs Stud. 2012 Aug 10
Abstract
Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha
for Chronic Hepatitis C.
Dhillon S, Kaker A, Dosanjh A, et AL
Dig Dis Sci. 2010 Apr 22.
Abstract

Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment
with interferon-alpha: a review.
Quelhas R, Lopes A.
J Psychiatr Pract. 2009 Jul;15(4):262-81
Abstract

Recombinant Interferon Alpha

Journal Papers, Abstracts, and Commentaries

Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant
interferon-alpha therapy.
Nguyen HV, Mollison LC, Taylor TW, et al
Intern Med J. 2006 Jun;36(6):362-6.
Paper

Interferon Alpha 2a

Interferon Alpha-2a/RBV

Journal Papers, Abstracts, and Commentaries

FULL-TEXT ARTICLE (Must be downloaded from site)
Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C: a retrospective study using the Japanese Interferon Database.
Sato I, Shimbo T, Kawasaki Y, Masaki N.
Drug Des Devel Ther. 2014 Dec 30;9:283-90.
Paper

Treatment profile of hepatitis C patients - a comparison of interferon alpha 2a
and 2b treatment regimes.
Aziz S, Qamar R, Ahmed I, et al
J Coll Physicians Surg Pak. 2010 Sep;20(9):581-5.
Abstract

Peripheral neuropathy during a second cycle of treatment with high doses of
interferon alpha in a patient with hepatitis C, and a review of the literature
Tellez Zenteno JF, Negrete Pulido O, et al.
Rev Neurol 2002 Oct 1;35(7):644-6
Abstract

FULL-TEXT ARTICLE
Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of
randomised trials.
Kjaergard LL, Krogsgaard K, Gluud C.
BMJ 2001 Nov 17;323(7322):1151-5
Paper

Interferon Alpha 2b

Interferon Alpha-2b/RBV

Journal Papers, Abstracts, and Commentaries

Two week induction of interferon-beta followed by pegylated interferon alpha-2b
and ribavirin for chronic infection with hepatitis C.
Matsui K, Iwabuchi S, Shimizu H, et al
Hepatol Res. 2010 Jun 8
Abstract

FULL-TEXT PDF ARTICLE
Exacerbation of hepatitis C induced subclinical hypoadrenalism by interferon-alpha2beta:
a case report.
Tran HA, Song S, Lojewski RJ, Reeves GE.
Cases J. 2008 Sep 18;1(1):157
Paper

Interferon alfa-2b continuous long-term therapy versus repeated 24-week cycles for retreating
chronic Hepatitis C.
McHutchison JG, Patel K, Schiff ER, et al
Aliment Pharmacol Ther. 2007 Dec 11
Abstract

Treatment of Early Diagnosed HCV Infection in Hemodialyzed Patients with Interferon-alpha.
Treatment of Hepatitis C.
Urbanek P, Tesar V, Prochazkova-Francisci E, et al
Blood Purif. 2004 Jul 16;22(4):344-350.
Abstract

Pretreatment hepatitis C virus dynamics for predicting virological response to
interferon-alpha2b monotherapy in patients with chronic hepatitis C virus infection.
Sainokami S, Abe K, Suzuki K, Ishikawa K. et al
Hepatol Res. 2003 Nov;27(3):181-191.
Abstract

Antiviral treatment in acute hepatitis C.
Macedo G, Correia A, Ribeiro T.
Hepatogastroenterology. 2003 Jul-Aug;50(52):1057-9.
Abstract

Daily or three times per week interferon alpha-2b in combination with ribavirin or
interferon alone for the treatment of patients with chronic hepatitis C not responding
to previous interferon alone.
de Ledinghen V, Trimoulet P, Winnock M, et al.
J Hepatol 2002 Jun;36(6):819-26
Abstract

Efficacy of daily induction dosing vs standard thrice weekly dosing of interferon-alpha2B
for initial treatment of chronic hepatitis C.
Gonzalez HJ, Ho SB, Gross JB. et al.
Dig Dis Sci 2002 Apr;47(4):784-92
Abstract

Interferon alpha/Ribavirin

Journal Papers, Abstracts, and Commentaries

Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin.
Oliveira IS, Carvalho LP, Schinoni MI, et al
Microb Pathog. 2015 Dec 21
Abstract
Homozygosity for HLA Group 2 Alleles Predicts Treatment Failure with Interferon-α and Ribavirin in Chronic Hepatitis C Virus Genotype 1 Infection.
Collison M, Chin JL, Abu Shanab A, et al
J Interferon Cytokine Res. 2014 Sep 19.
Abstract

Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance |
treatment.
Neukam K, Mira JA, Gilabert I, et al
Eur J Clin Microbiol Infect Dis. 2011 Oct 6
Abstract

Changes in Depressive Symptoms and Impact on Treatment Course Among Hepatitis C Patients
Undergoing Interferon-α and Ribavirin Therapy: A Prospective Evaluation.
Chapman J, Oser M, Hockemeyer J, et al
Am J Gastroenterol. 2011 Aug 9.
Abstract

Sexual Dysfunction in Chronic Hepatitis C Virus Patients Treated with Interferon Alpha and Ribavirin.
Malaguarnera M, Vicari E, Calogero A,
J Interferon Cytokine Res. 2008 Sep 8.
Abstract

Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely
associated with increased dynamism of intrahepatic natural killer and natural killer T cells.
Yamagiwa S, Matsuda Y, Ichida T, et al
Hepatol Res. 2008 Mar 4
Abstract

Fulminant central nervous system demyelination associated with interferon-{alpha} therapy and
hepatitis C virus infection.
H�ftberger R, Garzuly F, Dienes HP,et a
Mult Scler. 2007 Nov;13(9):1100-6.
Abstract

FULL TEXT ARTICLE
Effect of sustained virological response on long-term clinical outcome in 113 patients with
compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin.
Braks RE, Ganne-Carrie N, Fontaine H., et al
World J Gastroenterol. 2007 Nov 14;13(42):5648-53
Paper

Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral
hepatitis C.
Sene D, Touitou V, Bodaghi B, et al
World J Gastroenterol. 2007 Jun 14;13(22):3137-3140.
Abstract

FULL-TEXT ARTICLE
Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients
with HCV genotype 2: A project of the Kyushu University Liver Disease Study Group.
Furusyo N, Katoh M, Tanabe Y, et al
World J Gastroenterol. 2006 Feb 7;12(5):784-90.
Paper

Effects of Adding Ribavirin to Interferon to Treat Chronic Hepatitis C Infection: A Systematic
Review and Meta-analysis of Randomized Trials.
Brok J, Gluud LL, Gluud C.
Arch Intern Med. 2005 Oct 24;165(19):2206-12.
Abstract

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.
Iwasaki Y, Ikeda H, Araki Y, et al
Hepatology. 2006 Jan;43(1):54-63.
Abstract

Interferon alpha-2a/Ribavirin

Journal Papers, Abstracts, and Commentaries

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Tural C, Sol� R, Alvarez NP, et al
Antivir Ther. 2011;16(6):833-841
Abstract

A case of peripheral facial nerve palsy with cryoglobulinemia and chronic thyroiditis occurring
during interferon plus ribavirin therapy for chronic hepatitis C.
Sumida Y, Kanemasa K, Fukumoto K, et al
Nippon Shokakibyo Gakkai Zasshi. 2007 Jun;104(6):815-21
Abstract

Diabetes mellitus reduces the therapeutic effectiveness of interferon-alpha2b plus ribavirin
therapy in patients with chronic hepatitis C.
Konishi I, Horiike N, Hiasa Y
Hepatol Res. 2007 May;37(5):331-6
Abstract

Interferon Alpha-2b/Ribavirin

     Journal Papers, Abstracts, and Commentaries

FULL-TEXT ARTICLE (Must be downloaded from site)
Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C: a retrospective study using the Japanese Interferon Database.
Sato I, Shimbo T, Kawasaki Y, Masaki N.
Drug Des Devel Ther. 2014 Dec 30;9:283-90.
Paper
Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV
genotype 2 patients: a single-centre study.
Rumi MG, Aghemo A, D'Ambrosio R. et al
Antivir Ther. 2007;12(7):1033-40.
Abstract

Interferon alfa-2b and ribavirin: new indication. In children: more risks than in adults.
[No authors listed
Prescrire Int. 2007 Apr;16(88):63-5.
Abstract

A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic
hepatitis C.
Krawitt EL, Gordon SR, Grace ND, et al
Am J Gastroenterol. 2006 Jun;101(6):1268-73.
Abstract

FULL-TEXT ARTICLE
Triple therapy of interferon and ribavirin with zinc supplementation for patients with
chronic hepatitis C: A randomized controlled clinical trial.
Suzuki H, Takagi H, Sohara N, Kanda D, et al
World J Gastroenterol. 2006 Feb 28;12(8):1265-9.
Paper

FULL-TEXT PDF ARTICLE
The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with
combination Interferon-alpha-2beta and Ribavirin.
Tran HA, Jones TL, Batey RG.
BMC Endocr Disord. 2005 Oct 12;5(1):8
Paper

Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked
lymphoproliferative syndrome.
Strnad-Trojan N, Linde R, Reichenbach J,et al
Eur J Pediatr. 2006 Feb 4;:1-3
Abstract

High-dose interferon-alpha2b induction therapy in combination with ribavirin for treatment of chronic
hepatitis C in patients with non-response or relapse after interferon-alpha monotherapy.
Hass HG, Kreysel C, Fischinger J. et al ;
World J Gastroenterol. 2005 Sep 14;11(34):5342-6.
Abstract

FULL-TEXT ARTICLE
Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy
during hepatitis C treatment: Outcome after resumption of therapy.
Wong VK, Cheong-Lee C, Ford JA, Yoshida EM.
World J Gastroenterol. 2005 Sep 14;11(34):5392-3.
Paper

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b
plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
Lee SD, Yu ML, Cheng PN, Lai MY, et al
J Viral Hepat. 2005 May;12(3):283-91.
Abstract

Exacerbation of Psoriasis due to Peginterferon alpha-2b plus Ribavirin Treatment of Chronic
Active Hepatitis C.
Kartal ED, Colak H, Ozgunes I, Usluer G.et al
Chemotherapy. 2005 May 9;51(2-3):167-169
Abstract

Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact
of treatment duration and viral kinetics on sustained virological response.
Kamal SM, El Tawil AA, Nakano T
Gut. 2005 Jun;54(6):858-66
Abstract

Case Report: Hemolytic Anemia During Pegylated IFN-alpha2b Plus Ribavirin Treatment for
Chronic Hepatitis C: Ribavirin Is Not Always the Culprit.
Gentile I, Viola C, Reynaud L, et al
J Interferon Cytokine Res. 2005 May;25(5):283-5
Abstract

The effect of adherence to therapy on sustained response in daily or three times a week "
interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis
C patients.
Raptopoulou M, Tsantoulas D, Vafiadi I, et al
J Viral Hepat. 2005 Jan;12(1):91-5
Abstract

Follow-up of Adverse Drug Reactions from Peginterferon alfa-2b-Ribavirin Therapy.
Bagheri H, Fouladi A, Barange K, et al
Pharmacotherapy. 2004 Nov;24(11):1546-1553.
Abstract

Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic
hepatitis C.
Dieperink E, Ho SB, Tetrick L, et al
Gen Hosp Psychiatry. 2004 May-Jun;26(3):237-4
Abstract

Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon alpha-2b Plus
Ribavirin.
Perez-Olmeda M, Soriano V, Asensi V,et al.
AIDS Res Hum Retroviruses. 2003 Dec;19(12):1083-1089
Abstract

First-line therapy with daily versus thrice-weekly interferon alfa-2b plus ribavirin for chronic
hepatitis C.
Reiser M, Buggisch P, Grossmann J, et al
Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1299-304
Abstract

Early prediction of nonresponders to treatment with interferon alpha-2b and ribavirin in
patients with
chronic hepatitis C.
Liu LW, Tomlinson G, Mazzulli T, et al.
Can J Gastroenterol. 2003 Aug;17(8):483-7.
Abstract

Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of
interferon non-responsive chronic hepatitis C: a randomised trial.
Adinolfi LE, Utili R, Tonziello A, Ruggiero G., et al.
Gut 2003 May;52(5):701-5
Abstract

A Prospective Study of Neuropsychiatric Symptoms Associated With Interferon-alpha-2b and
Ribavirin Therapy for Patients With Chronic Hepatitis C.
Thuras P, et al
Psychosomatics 2003 Mar-Apr;44(2):104-12
Abstract

Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus
ribavirin for initial treatment of chronic hepatitis C.
Siebert U, Sroczynski G, Rossol S, et al.
Gut 2003 Mar;52(3):425-32
Abstract

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation:
a randomized study.
Samuel D, Bizollon T, Feray C, Roche B, et al.
Gastroenterology 2003 Mar;124(3):642-50
Abstract

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of
patients with chronic hepatitis C relapsing after interferon monotherapy.
Saracco G, Olivero A, Ciancio A, et al.
Hepatology 2002 Oct;36(4 Pt 1):959-66
Abstract
FULL-TEXT ARTICLE
Treatment of acute hepatitis C virus infection with interferon-alpha 2b and ribavirin:
Case report and review of the literature.

Leblebicioglu H, Bayirli D, Esen S, et al
Ann Clin Microbiol Antimicrob 2002 Oct 14;1(1):3
Paper

Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.
Fontana RJ, Schwartz SM, Gebremariam A, et al.
Psychosomatics 2002 Sep-Oct;43(5):378-85
Abstract

Interferon Alpha-2b/Ribavirin

   Journal Papers, Abstracts, and Commentaries

FULL-TEXT PDF ARTICLE
Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic
hepatitis C patients with genotype 2 and high virus load.
Arase Y, Suzuki F, Akuta N, et al
Intern Med. 2010;49(11):965-70
Paper

Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients
with chronic hepatitis C.
Uyama H, Nakamura H, Hayashi E, et al
Hepatol Res. 2007 May;37(5):325-30.
Abstract

Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b
and ribavirin.
Kraus M, Schafer A, Wissmann S, et al
Clin Pharmacol Ther. 2005 Jan;77(1):90-100
Abstract

Histamine Dihydrochloride and Interferon-Alpha-2b

     Journal Papers, Abstracts, and Commentaries

A multicentre, randomized study to evaluate the safety and efficacy of
histamine dihydrochloride and interferon-alpha-2b for the treatment of chronic hepatitis C.
Lurie Y, Nevens F, Aprosina ZG, et al.
J Viral Hepat 2002 Sep;9(5):346-353
Abstract

Interferon Beta: General Reports

    Journal Papers, Abstracts, and Commentaries

FULL TEXT PDF ARTICLE
The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with
low virus load.
Kawamura Y, Arase Y, Ikeda K, et al
Intern Med. 2008;47(5):355-60.
Paper

FULL-TEXT PDF ARTICLE
Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in
chronic hepatitis C patients with genotype 1b and high virus load.
Arase Y, Suzuki F, Akuta N, et a
Intern Med. 2010;49(11):957-63
Paper

Safety of interferon beta treatment for chronic HCV hepatitis.
World J Gastroenterol. 2004 Jan;10(1):12-6
Abstract



Albinterferon-alfa 2b

   Journal Papers, Abstracts, and Commentaries

Albinterferon-alfa 2b: a new treatment option for hepatitis C.
Flisiak R, Flisiak I.
Expert Opin Biol Ther. 2010 Sep 9
Abstracts

HCV Drugs Main Page Main New/Newsworthy Home Page

Interferon Therapy- HCV Indications

Medical Advocates HCV Infection/Disease
	Interferon Therapy
	General Reports Consensus Interferon Interferon Alpha Recombinant Interferon-Alpha Interferon Alpha/RBV Interferon Alpha-2a Interferon Alpha-2b Interferon Alpha-2a/RBV Interferon Alpha-2b/RBV Interferon Alpha-2b/RBV/AMT	Interferon Beta Albinterferon-alfa 2b Peg Interferon-Alfa-2a Peg Interferon-Alfa-2b